end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesCurrent,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsFairValueDisclosure,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,DeferredCosts,DeferredOfferingCosts,DepreciationDepletionAndAmortization,DerivativeGainLossOnDerivativeNet,DerivativeLiabilitiesCurrent,DerivativeLiabilitiesNoncurrent,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateContinuingOperations,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FederalIncomeTaxExpenseBenefitContinuingOperations,GeneralAndAdministrativeExpense,IncomeLossFromEquityMethodInvestments,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities,IncreaseDecreaseInDerivativeLiabilities,IncreaseDecreaseInOperatingLeaseLiability,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InvestmentIncomeInterest,LesseeOperatingLeaseLiabilityPaymentsDue,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesFairValueDisclosure,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseExpense,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLeasesRentExpenseNet,OtherAssetsNoncurrent,PaymentsOfStockIssuanceCosts,PaymentsToAcquireInterestInJointVenture,PaymentsToAcquirePropertyPlantAndEquipment,PrepaidExpenseCurrent,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,ResearchAndDevelopmentInProcess,RestrictedCash,RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings,RetainedEarningsAccumulatedDeficit,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,StateAndLocalIncomeTaxExpenseBenefitContinuingOperations,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueRestrictedStockAwardGross,StockIssuedDuringPeriodValueStockOptionsExercised,UnrealizedGainLossOnDerivatives,WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2021-09-30,2021-11-15,10-Q,"Pyxis Oncology, Inc.",PYXS,CIK0001782223,USD,1927000.0,5462000.0,3448000.0,307000.0,307000.0,,139488000.0,134336000.0,0.0,133477000.0,133586000.0,133586000.0,,28418977.0,0.001,167000000.0,2194326.0,1639600.0,2000.0,3501000.0,1100000.0,,-2560000.0,9123000.0,67000.0,-8.96,0.0,10800000.0,,3772000.0,,,,,,,6000.0,300000.0,16904000.0,139488000.0,16837000.0,0.0,,,,-14175000.0,-2554000.0,11621000.0,-11621000.0,,325000.0,,388000.0,200000.0,109000.0,,,,859000.0,,,,,1154000.0,7849000.0,,109000.0,,-74889000.0,,,554724.0,,0.0,0.7313,0.7288,0.0096,0.0081,927403.0,4.89,,,5.59,34755000.0,3530706.0,6.16,,,,10304000.0,,-71439000.0,,,3000.0,14000.0,,1581610.0
